Roctavian, Hem A Gene Therapy, Sustains Drop in Bleeding Rates, Fase 3 Data Show

Roctavian, Hem A Gene Therapy, Sustains Drop in Bleeding Rates, Fase 3 Data Show

Notícias sobre hemofilia hoje